Cencora, Inc. (COR) – What Are Analysts Saying About This Stock?

Shares of Cencora, Inc. (NYSE:COR) have been given a consensus rating of “Moderate Buy” by the eighteen analysts that are currently covering the company, Marketbeat Ratings reports. Four research analysts have rated the stock with a hold recommendation and fourteen have given a buy recommendation to the company. The average 1-year price objective among analysts that have covered the stock in the last year is $368.38.

A number of brokerages have issued reports on COR. Citigroup reissued a “buy” rating on shares of Cencora in a report on Thursday, August 6th. Weiss Ratings raised shares of Cencora from a “buy (b-)” rating to a “buy (b)” rating in a report on Tuesday, October 6th. Wells Fargo & Company increased their target price on shares of Cencora from $331.00 to $395.00 and gave the stock an “overweight” rating in a research note on Tuesday, August 11th. Royal Bank Of Canada reissued a “sector perform” rating and issued a $330.00 price objective on shares of Cencora in a report on Tuesday, September 8th. Finally, Argus increased their target price on Cencora from $340.00 to $380.00 and gave the company a “buy” rating in a research report on Tuesday, October 20th.

Insider Activity

In other news, EVP Elizabeth Campbell sold 11,300 shares of Cencora stock in a transaction dated Monday, August 24th. The shares were sold at an average price of $324.12, for a total value of $3,662,556.00. Following the sale, the executive vice president owned 19,455 shares in the company, valued at $6,305,754.60. This trade represents a 36.74% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.38% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On Cencora

Several institutional investors have recently bought and sold shares of the company. Cornerstone Wealth Group LLC raised its position in Cencora by 1.6% in the first quarter. Cornerstone Wealth Group LLC now owns 2,434 shares of the company’s stock valued at $760,000 after purchasing an additional 38 shares during the last quarter. Pinnacle Associates Ltd. increased its stake in Cencora by 1.8% in the third quarter. Pinnacle Associates Ltd. now owns 2,203 shares of the company’s stock valued at $662,000 after purchasing an additional 38 shares in the last quarter. Staley Capital Advisers Inc. boosted its holdings in Cencora by 0.7% in the first quarter. Staley Capital Advisers Inc. now owns 6,127 shares of the company’s stock worth $1,925,000 after acquiring an additional 40 shares in the last quarter. Elmwood Wealth Management Inc. raised its holdings in Cencora by 0.9% during the second quarter. Elmwood Wealth Management Inc. now owns 4,314 shares of the company’s stock worth $1,221,000 after buying an additional 40 shares during the last quarter. Finally, Signature Equity Partners LLC boosted its stake in Cencora by 4.6% during the 1st quarter. Signature Equity Partners LLC now owns 937 shares of the company’s stock valued at $294,000 after purchasing an additional 41 shares during the last quarter. 97.52% of the stock is currently owned by institutional investors and hedge funds.

Cencora Trading Up 0.1%

NYSE COR opened at $330.70 on Monday. The company has a market capitalization of $63.11 billion, a PE ratio of 24.57, a P/E/G ratio of 1.69 and a beta of 0.58. The company has a fifty day moving average of $323.34 and a 200 day moving average of $317.53. Cencora has a 1 year low of $244.82 and a 1 year high of $377.54. The company has a debt-to-equity ratio of 3.53, a current ratio of 0.93 and a quick ratio of 0.58.

Cencora (NYSE:COR) last announced its quarterly earnings results on Wednesday, August 5th. The company reported $4.48 earnings per share for the quarter, topping the consensus estimate of $4.35 by $0.13. The company had revenue of $84.75 billion for the quarter, compared to the consensus estimate of $84.31 billion. Cencora had a return on equity of 125.45% and a net margin of 0.79%. The firm’s revenue for the quarter was up 5.1% compared to the same quarter last year. During the same period last year, the firm earned $4.00 EPS. Research analysts forecast that Cencora will post 17.87 earnings per share for the current year.

Cencora Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Monday, August 31st. Shareholders of record on Friday, August 14th were issued a dividend of $0.60 per share. This represents a $2.40 annualized dividend and a yield of 0.7%. The ex-dividend date of this dividend was Friday, August 14th. Cencora’s dividend payout ratio (DPR) is presently 17.83%.

About Cencora

Cencora, formerly known as AmerisourceBergen, is a global pharmaceutical sourcing and distribution company. It provides branded, generic and specialty pharmaceuticals, over-the-counter products and related health care supplies to pharmacies, hospitals, health systems, physician practices and other health care providers.

The company also offers services to pharmaceutical and biotechnology manufacturers, including logistics, commercialization support, market access, consulting, clinical trial support and patient assistance programs.